✦ LIBER ✦

Effect of CYP2C19 2 and 17 mutations on pharmacodynamics and kinetics of proton pump inhibitors in Caucasians

✍ Scribed by Nicole G. Hunfeld; Ron A. Mathot; Daan J. Touw; Ron H. Van Schaik; Paul G. Mulder; Paul F. Franck; Ernst J. Kuipers; William P. Geus

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Impact of the CYP2C19*17 Polymorphism on

✍ Mazer-Amirshahi, Maryann; van den Anker, John 📂 Article 📅 2013 🏛 Sage Publications 🌐 English ⚖ 102 KB

Effect of CYP2C19 Genetic Polymorphism o

✍ Cho, Hoon; Choi, Min-Koo; Cho, Doo-Yeon; Yeo, Chang-Woo; Jeong, Hye-Eun; Shon, J 📂 Article 📅 2012 🏛 Sage Publications 🌐 English ⚖ 273 KB

Dose of Proton Pump Inhibitors and the C

📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 34 KB

P.04.25 ROLE OF CYP2C19*17 AND CYP2C19*2

✍ Franceschi, M.; Seripa, D.; Giulia, P.; Bazzano, S.; Gravina, C.; Urbano, M.; Ba 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 75 KB

CYP2C19 Genotype and Pharmacokinetics of

✍ Toshiyuki Sakai; Nobuo Aoyama; Tomoko Kita; Toshiyuki Sakaeda; Kohshi Nishiguchi 📂 Article 📅 2001 🏛 Springer US 🌐 English ⚖ 163 KB

Drug interaction of tacrolimus and proto

✍ F Itagaki; M Homma; K Yuzawa; K Fukao; Y Kohda 📂 Article 📅 2002 🏛 Elsevier Science 🌐 English ⚖ 54 KB

Effect of CYP2C19 *2 and *17 mutations on pharmacodynamics and kinetics of proton pump inhibitors in Caucasians